TMBIM4 and Cognitive impairment: In transgenic mouse and zebrafish models of WS1, the activation of S1R was obtained through the S1R agonist PRE-084 and allowed to reverse locomotor and cognitive deficits, highlighting a potential disease-modifying approach (50).